Test Code BMIPB Borrelia miyamotoi Detection, PCR, Blood
Ordering Guidance
This assay does not detect the Borrelia species that cause Lyme disease. If Lyme disease is suspected, order SLYME / Lyme Antibody Modified 2-Tier with Reflex, Serum.
Specimen Required
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Royal blue top (EDTA), pink top (EDTA), or sterile vial containing EDTA-derived aliquot
Specimen Volume: 1 mL
Collection Instructions: Send whole blood specimen in original tube (preferred).
Useful For
Aiding in the diagnosis of Borrelia miyamotoi infection in conjunction with clinical findings
Preferred method for detection of B miyamotoi using blood specimens
Testing Algorithm
For information see Acute Tickborne Disease Testing Algorithm.
Special Instructions
Reporting Name
Borrelia miyamotoi Detection, PCR, BSpecimen Type
Whole Blood EDTASpecimen Minimum Volume
0.3 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Whole Blood EDTA | Refrigerated (preferred) | 7 days |
| Frozen | 7 days |
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
Reference Values
Negative
Reference values apply to all ages.
Supportive Data
The following assay verification data supports the use of this assay for clinical testing.
Accuracy/Diagnostic Sensitivity and Specificity:
Clinical Samples:
Sixty-two clinical EDTA blood specimens received in the clinical laboratory for Ehrlichia/Anaplasma polymerase chain reaction (PCR) were tested using the Borrelia miyamotoi PCR assay. Results were compared to the Minnesota Department of Health 16S rRNA TaqMan assay. In addition, 2 retrospectively identified B miyamotoi-positive specimens were confirmed by the B miyamotoi PCR assay and the MDH TaqMan assay.
Spiking studies:
To supplement the clinical specimens, negative whole blood and spinal fluid (CSF) specimens were spiked with genomic or plasmid DNA of B miyamotoi near the limit of detection and tested in a blinded fashion. The sensitivity of the PCR assay was 100% and the specificity with spiked specimens was 100%. The samples were extracted and tested in a blinded fashion.
Analytical Sensitivity/Limit of Detection:
The limit of detection is 2800 target copies/mL (5.6 target copies/mcL) of whole blood or CSF.
Analytical Specificity:
No PCR signal was obtained from the extracts of 31 bacterial, viral, parasitic, and fungal isolates from similar organisms or from organisms commonly found in the specimens tested.
Precision:
Interassay and intra-assay precision were 100%.
Reference Range:
The reference range of this assay is negative. This assay is designed to detect only species of clinical significance and is to be used for patients with a clinical history and symptoms consistent with tickborne relapsing fever. It should not be used to screen healthy patients.
Reportable Range:
This is a qualitative assay, and the results are reported as negative or positive for B miyamotoi DNA.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 4 daysSpecimen Retention Time
1 weekPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
87478
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| BMIPB | Borrelia miyamotoi Detection, PCR, B | 82475-5 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 618298 | B. miyamotoi PCR, B | 82475-5 |
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.